Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
ADAMN Adamas Pref far exceeds Q4 2025 earnings expectations shares rise modestly in todays trading Does Hongli Group HLP stock justify its valuation In Focus 20260420 Is Emmis EMIS stock forming a squeeze pattern Flatline 20260420 Euronet Worldwide EEFT Stock Why Day Traders Love It Overhead Buying 20260420 Western HYI Stock Daily Review Sideways 20260420 iShares MSCI Canada ETF EWC Secures NearTerm Tariff Relief Via USMCA Exemption But Structural Policy Risks Persist TBCH Turtle shares rise 249 percent despite Q4 2025 earnings missing analyst expectations by 237 percent TPST Tempest Therapeutics tops Q4 2025 EPS estimates shares jump more than 14 percent in todays trading VolitionRX Limited VNRX Investment Case Q4 2025 Earnings Underperform Diamondrock DRH Slides 195 as Selling Pressure Mounts 20260515 AIs Sustainability Challenge Two Researchers Aim to Rebalance the Equation Paysign PAYS Gained 266 Can It Break 629 20260514 Cristiano Ronaldo Adds Free Sports Streaming Channel to His Business Empire Ahead of the 2026 World Cup Nvidia Revenue Surpasses Wall Street Expectations as AI Infrastructure Expansion Accelerates MapLight Therapeutics MPLT Q1 2026 Earnings Slump EPS Falls Short of 112 Target Berkshire Hathaway Filing May Reveal Warren Buffetts Tiny Purchase Hinted at in March Ethos Technologies LIFE Reports Strong Q1 2026 Revenue NA EPS Beats RingCentral RNG Q1 2026 Earnings EPS Beat Drives Stock Higher NBHC Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment Despite Resilient Operations TR Q3 2023 Earnings EPS of 049 Reported Stock Declines 118 InMed Pharmaceuticals Q3 2025 Earnings Net Loss Widens Amid Pipeline Focus SBDS Q1 2026 Earnings Significant Loss Reported Amidst Operational Challenges Norwood Financial Corp NWFL Gains 24 as Regional Banking Sector Shows Resilience Sharps Technology Inc STSS Edges Higher Testing Key Resistance at 194 Markel Group Inc MKL Slightly Lower as RangeBound Trading Persists Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29